Aerpio Pharmaceuticals, Inc.
ARPO · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 371.7% | 23.1% | 443.6% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 0% | -535.7% | -347.4% | -1,655% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -259.6% | -654.6% | -506.3% | -2,487.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -245.1% | -670.2% | -517.5% | -2,695.1% |
| EPS Diluted | -2.36 | -1.08 | -0.96 | -1.35 |
| % Growth | -118.5% | -12.5% | 28.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |